KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non Operating Income (2016 - 2017)

Jazz Pharmaceuticals has reported Non Operating Income over the past 3 years, most recently at -$1.5 million for Q1 2017.

  • Quarterly Non Operating Income fell 78.75% to -$1.5 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Mar 2017, down 87.28% year-over-year, with the annual reading at $1.4 million for FY2015, 83.36% down from the prior year.
  • Non Operating Income was -$1.5 million for Q1 2017 at Jazz Pharmaceuticals, down from -$749000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $2.2 million in Q1 2015 and troughed at -$1.9 million in Q2 2015.
  • The 3-year median for Non Operating Income is -$819000.0 (2016), against an average of -$226714.3.
  • Peak annual rise in Non Operating Income hit 23.34% in 2016, while the deepest fall reached 136.48% in 2016.
  • Tracing JAZZ's Non Operating Income over 3 years: stood at $2.1 million in 2015, then tumbled by 135.82% to -$749000.0 in 2016, then plummeted by 95.46% to -$1.5 million in 2017.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$1.5 million, -$749000.0, and -$819000.0 for Q1 2017, Q3 2016, and Q1 2016 respectively.